This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

In Global News: Endocarditis in Illicit Drug Users, ERAS Cardiac Surgery Consensus Statement, and NSCLC Upstaging

Friday, May 4, 2018

Submitted by



Claire Vernon

Patient Care and General Interest

An article in the New York Times looks at the ethical dilemma of performing surgery for endocarditis in illicit drug users whose addictions go untreated.

ERAS® Cardiac Surgery presented an expert consensus statement on best practices to speed recovery at the Enhanced Recovery After Cardiac Surgery session at the recent AATS Annual Meeting in San Diego, California.


Drugs and Devices

The Australian Research Council Research Hub for Advanced Manufacturing of Medical Devices has been launched at the University of Queensland as part of an initiative to drive innovation by supporting collaborative research between academic and industry groups.

The Cardioband transcatheter tricuspid valve reconstruction system from Edwards Lifesciences has received CE Mark approval.


Research, Trials, and Funding

Terumo Aortic has launched an early feasibility study to evaluate the safety and efficacy of its RelayBranch thoracic stent-graft system.

Research presented at the recent AATS Annual Meeting suggests that the likelihood of upstaging increases with each week between staging and surgery for non-small cell lung cancer, which supports sooner surgery to avoid cancer progression and improve the likelihood of curative resection.

Add comment

Log in or register to post comments